Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study
Meera Agar(University of Technology Sydney), Eng‐Siew Koh(Liverpool Hospital), Anna K. Nowak(The University of Western Australia), Robyn Leonard(The University of Sydney), Rosemary Harrup(University of Tasmania), Elizabeth H Barnes, Ganessan Kichenadasse(Flinders University), Hao‐Wen Sim(The University of Sydney), Janette L. Vardy(The University of Sydney), Elizabeth Hovey, Cecelia Gzell(Australian and New Zealand Intensive Care Society), Anthony Dowling(Monash University), Benjamin Y. Kong(Prince of Wales Hospital), Helen Wheeler(The University of Sydney), Desma Spyridopoulos(The University of Sydney), Merryn Hall(Cooperative Trials Group for Neuro-Oncology), Tracey Dunlop(St George Hospital), Zarnie Lwin(The University of Queensland), Ross Jennens, John Simes(The University of Sydney), Evonne Tim(The University of Sydney)
Cited by 0
Related Papers
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
|The Lancet|2019|785
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
|Blood|2019|369
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
|The Lancet Oncology|2021|333
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2023|332